In 2023, Samsung Biologics conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2023, Samsung Biologics generated a total of 10,676 metric tonnes of waste.
Of this amount, 83.81% of Samsung Biologics's total waste generated was recovered through methods such as recycling, reuse, or composting, while 16.19% was disposed of through landfilling, incineration, or combustion.
In 2023, Samsung Biologics reported a total waste generation of 10,676 metric tonnes, of which 83.81% was recovered through recycling, reuse, or composting. This high recovery rate suggests that Samsung Biologics has implemented strong circular economy practices and actively prioritizes sustainable waste management.
Since 2021, Samsung Biologics's total waste generation increased by 27.52%, including a 4.42% increase in 2023, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.
Over the same period, Samsung Biologics's waste recovery rate increased by 14.6%, including a 12.71% rise in 2023, indicating growing emphasis on circularity and improved operational practices for diverting waste from disposal.
Overall, Samsung Biologics has seen a consistent rise in waste generation both over the long term and in the year 2023. However, the company has also steadily improved its waste recovery performance, suggesting that it is actively working to offset the environmental consequences of increased production through enhanced circularity efforts.
In 2023, Samsung Biologics generated a total of 10,676 metric tonnes of waste.
Of this amount, 14.66% of Samsung Biologics's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 85.34% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2021, Samsung Biologics's total waste generation increased by 27.52%, including a 4.42% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, the share of hazardous waste in Samsung Biologics's total output increased by 87.73%, including a further 34.11% rise in 2023, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.
Overall, Samsung Biologics has seen a continuous rise in both total waste and hazardous waste over time, signaling a worsening environmental impact that may require urgent reassessment of material sourcing, production processes, or waste mitigation strategies.
In 2023, Samsung Biologics reported that 1,565 metric tonnes of its total waste output were classified as hazardous. This represents 14.66% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. Only 3.83% of hazardous waste was recovered, meaning the vast majority was treated through disposal methods such as landfilling or incineration. This raises concerns about the environmental and health risks associated with Samsung Biologics’s current hazardous waste practices.